Skip to main content
OpenTrials

Clinical trial condition

Opioid Use Disorder

Explore clinical trials studying Opioid Use Disorder. Study availability and eligibility vary by location and protocol.

380 public trials 128 recruiting studies
Refine in advanced search Browse all conditions

Opioid Use Disorder trial results

Recruiting

A Study of Brenipatide in Participants With Opioid Use Disorder

NCT07420283

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations
  • NoesisPharma - Phoenix - East Shea Boulevard Phoenix, Arizona, United States
  • Pillar Clinical Research- Little Rock Little Rock, Arkansas, United States
  • Woodland International Research Group Little Rock, Arkansas, United States
  • Ark Clinical Research - Fountain Valley Fountain Valley, California, United States
View all 59 locations
View Trial Details
Recruiting

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

NCT06323824

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations
  • Highland Hospital Bridge Clinic at Alameda Health System Oakland, California, United States
  • Outpatient Buprenorphine Induction Clinic, University of California, San Francisco San Francisco, California, United States
  • Rapid Start Clinic, Kaiser Permanente Colorado Denver, Colorado, United States
  • Officed Based Addiction Treatment Program, Boston Medical Center Boston, Massachusetts, United States
View Trial Details
Recruiting

Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial

NCT06565416

Conditions
Chemically-Induced Disorders, Chronic Pain, Mental Disorders, +9 more
Locations
  • Clinic Site A (blinded pending tribal approval) Arcata, California, United States
  • Clinic Site C (blinded pending tribal approval) Minneapolis, Minnesota, United States
  • Clinic Site B (blinded pending tribal approval) Toppenish, Washington, United States
View Trial Details
Recruiting

A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

NCT04375033

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations
  • Tuscaloosa VA Medical Center, Tuscaloosa, AL Tuscaloosa, Alabama, United States
  • Phoenix VA Health Care System, Phoenix, AZ Phoenix, Arizona, United States
  • VA Long Beach Healthcare System, Long Beach, CA Long Beach, California, United States
  • VA Palo Alto Health Care System, Palo Alto, CA Palo Alto, California, United States
View all 25 locations
View Trial Details

Related conditions